Dr Reddys Laboratories Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹8,753.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.85 per cent from ₹8,828.30 crore. This corresponds to a year-on-year *(YoY) growth of 4.44 per cent.
Operating Profit
Operating Profit stands at ₹1,914.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 7.83 per cent from ₹2,077.20 crore. This corresponds to a year-on-year *(YoY) decline of 15.76 per cent.
PBDT
PBDT stands at ₹2,064.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.23 per cent from ₹2,249.40 crore. This corresponds to a year-on-year *(YoY) decline of 12.00 per cent.
Profit Before Tax
Profit Before Tax stands at ₹1,543.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.55 per cent from ₹1,744.80 crore. This corresponds to a year-on-year *(YoY) decline of 17.67 per cent.
Net Profit
Net Profit stands at ₹1,189.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.01 per cent from ₹1,336.80 crore. This represents a 15.28 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Dr Reddys Laboratories Ltd News
Dr Reddys Laboratories Ltd Earnings
- YOY
- QOQ
Dr Reddys Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dr Reddys Laboratories Ltd Research Reports
Dr Reddys Laboratories Ltd Financial Reports
Dr Reddys Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Reddy's Labs | -0.27% | 0.31% | 4.03% | 1.89% | 3.26% | 13.38% |
| Sun Pharma.Inds. | -0.19% | 0.65% | 3.22% | -2.56% | 10.69% | 8.38% |
| Divi's Lab. | -1.75% | -1.90% | 4.42% | -0.59% | 4.40% | 12.99% |
| Torrent Pharma. | -0.96% | -0.19% | 9.89% | 15.20% | 19.93% | 41.54% |
| Cipla | -2.91% | -2.61% | -1.38% | -12.35% | -14.85% | -10.22% |
| Lupin | -0.31% | 0.13% | 6.28% | 11.25% | 18.35% | 14.11% |
| Mankind Pharma | -2.22% | -2.34% | 6.58% | 0.44% | -14.88% | -3.49% |
Company Info
Company Information
Co-Chairman & Managing Director : G V Prasad
Executive Chairman : K Satish Reddy
Independent Director : Shikha Sanjaya Sharma
Independent Director : Leo Puri
Independent Director : K P Krishnan
Independent Director : Pennv Wan
Company Sec. & Compli. Officer : K Randhir Singh
Independent Director : Arun M. Kumar
Independent Director : Claudio Albrecht
Independent Director : Sanjiv Mehta
Independent Director : Alpna Seth